Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,465,313
-$237,787 QoQ
Shares Held
94,851
+0.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#527
of 2,514 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz SE holds $193,228,091 across 11 Drug Manufacturers - General names. BMY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
2,683,370 | $64,615,548 | |
| 2 | LLY |
ELI LILLY & Co
|
31,653 | $37,965,558 | |
| 3 | JNJ |
Johnson & Johnson
|
89,438 | $22,714,568 | |
| 4 | ABBV |
AbbVie Inc.
|
83,772 | $21,080,385 | |
| 5 | AZN |
Astrazeneca PLC
|
79,986 | $15,166,944 | |
| 6 | MRK |
Merck & Co., Inc.
|
112,208 | $14,418,728 | |
| 7 | AMGN |
Amgen Inc
|
31,246 | $11,314,800 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
94,851 | $5,465,313 |
All Filings in BMY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,465,313 | 94,851 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $5,703,100 | 94,033 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,601,668 | 103,850 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,240,887 | 94,033 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,380,097 | 94,623 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $6,106,562 | 100,124 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $5,728,791 | 101,287 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,535,692 | 126,318 | Shares | Defined | 2025-05-12 | |
| 2024-06-30 | $4,223,392 | 101,695 | Shares | Defined | 2025-05-12 | |
| 2024-03-31 | $6,322,295 | 116,583 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||